Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Comment by LithLoveron Dec 07, 2021 10:35am
76 Views
Post# 34206094

RE:RE:RE:RE:RE:Quick fondamental and technical analysis

RE:RE:RE:RE:RE:Quick fondamental and technical analysisPointing out that the history of the last few financings takes a few weeks to get above the PP price.  Have a great day and feel free to place me on ignore.  


IainCaimbeul wrote:
LithLover wrote: Look to the last 3 or 4 financings it took a few weeks for the price to exceed the PP price.

I expect the same here with the PP being $0.45.

There has also been a lot of digging and have uncovered the fact that the company is close to a full roll out accross the US and same with the UK mentioned in the video interview with the COO.

Might be some tax loss selling at the end of the month but I expect if the price is not above $0.45 by end of December it will be in January and we will start to get a series of announcements on the new spokes in the hub and spoke model.  



MarketMoney wrote:

 

13X2413 wrote: Thanks for that, but stock price going the wrong way. 

 

 

Your welcome :-)

Stockmarket has is own way so that's why if you follow the day every hour or day.....could be quite stressing for your heart :-)

Better with a mid/long term vision....less stressfull


 


Just give the shameless pumping a rest and let the market do it's work.


<< Previous
Bullboard Posts
Next >>